After tremendous work and effort, under the leadership of Associate Research Professor Elaina Goldstein, M.P.A., J.D., the University of Rhode Island has been awarded a CMS Health Care Innovation Award, this will be a truly interdisciplinary effort involving 4 of the 8 degree granting colleges at URI!
Project Title: "Living Rite-A Disruptive Solution for Management of Chronic Care Disease (a focus on adults with disabilities: intellectual and developmental diagnoses and dementia patients with 2 or more chronic conditions)"
The University of Rhode Island is receiving a three year $14 million award for a plan to use interdisciplinary care management teams, including community health workers, combined with using the Multiple Health Behavior Change technique to teach patients how to best manage their chronic diseases, to provide comprehensive and preventive care for intellectually and developmentally challenged dual eligible beneficiaries of Medicare and Medicaid who are at least 20 years old and citizens of Rhode Island. The program is estimated to yeild savings of $15.5 million, to train 226 workers and create 31 jobs.
Frontiers in Pharmaceutical Sciences: Global Perspectives
September 28 - September 30, 2012
Students in public health class to administer fake anti-virals to test emergency response
KINGSTON, R.I. – April 24, 2012 – Don’t be alarmed if you see a person dressed in a biohazard suit Thursday afternoon outside the University of Rhode Island’s Memorial Union.
That individual will just be watching for zombies and making sure they don’t get anywhere near the Ram’s Den while URI pharmacy students try to keep the virus that causes zombiism from spreading.
From 2 to 3:30 p.m., 25 pharmacy students will be running a mock dispensing clinic, during which anti-viral medications mockingly named Zombivir and Gummivir (really just Sour Patch and Gummy Bears candies) will be given to individuals to prevent the disease’s spread.
The mock distribution clinic is the brainchild of Jeffrey Bratberg, URI clinical associate professor of pharmacy and an expert on bioterrorism, pandemics and natural disasters who serves on the Rhode Island Disaster Medical Assistance Team, which completed two tours of New Orleans after Hurricane Katrina in 2005. Full Story
KINGSTON, R.I. – April 16, 2012 -- The University of Rhode Island College of Pharmacy and The Matty Fund are teaming up to help parents of children with epilepsy who want information about pharmaceuticals used to treat the disease.
URI Clinical Associate Professor of Pharmacy Practice Brett Feret will answer questions at an Epilepsy Medication Parent Workshop April 24th at the Crown Plaza in Warwick.
“Pharmacy is an important piece of epilepsy treatment,” said Feret, explaining that a majority of children with epilepsy are on medicines that can be difficult to take and have side effects. Full Story
Metabolism management could be key
KINGSTON, R.I. – January 4, 2012 – Abraham Kovoor was studying a brain protein, called RGS9-2, that he had previously related to the involuntary, random and repetitive body movements that are side effects of drugs used to treat Parkinson’s disease and schizophrenia.
While studying these side effects, which are called dyskinesia, Kovoor, an assistant professor in the University of Rhode Island’s College of Pharmacy, discovered that RGS9-2 also plays a role in regulating body weight.
Results of his study were published in the November issue of PLoS One, an interactive open-access, peer-reviewed scientific and medical research journal. Full Story